Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

15-5022 - Takeda Pharmaceuticals U.S.A., et al v. Sylvia Burwell, et al


Download Files

Metadata

Document in Context
15-5022 - Takeda Pharmaceuticals U.S.A., et al v. Sylvia Burwell, et al
July 15, 2016
PDF | More
PER CURIAM JUDGMENT [1624886] filed (without memorandum) ORDERED and ADJUDGED that the portion of the appeal seeking review of FDA's decision to approve Mitigare without Hikma's certifying to the Colcrys patents be DISMISSED AS MOOT and that this portion of the judgment of the District Court be VACATED. It is FURTHER ORDERED and ADJUDGED that the portion of the judgment of the District Court regarding Takeda’s challenge to FDA’s approval of the Mitigare label be AFFIRMED. (SEE JUDGMENT FOR DETAILS) withholding issuance of the mandate. Before Judges: Kavanaugh, Wilkins and Silberman. [15-5021, 15-5022]